Successful Prevention of Posttransfusion Hepatitis B by the Combined Use of Immunoglobulin, Vaccine and Interferon

By Ohto H.   Imamura S.   Sato A.   Kiyosawa K.  

Transfusion and Apheresis Science, Vol. 18, Iss. 4, 1997-12 ,pp. : 541-542

Elsevier

Access to resources Recommend Favorite

Use of combined treatment of hepatitis B immune globulin and lamivudine as prevention of hepatitis B virus recurrence in liver allograft

By Albeniz Arbizu E.   Barcena Marugan R.   Oton Nieto E.   Mateo Lindeman M.   Garcia Gonzalez M.   de Vicente Lopez E.   Moraleda Garcia G.  

Transplantation Proceedings, Vol. 35, Iss. 5, 2003-08 ,pp. : 1844-1845

Elsevier

Access to resources Recommend Favorite

Liver transplantation for patients with hepatitis B: prevention of hepatitis B recurrence by intravenous antihepatitis B immunoglobulin and lamivudine

By Lee P.H.   Hu R.H.   Tsai M.K.   Ho M.C.   Lai H.S.   Lai M.Y.   Yang P.M.  

Transplantation Proceedings, Vol. 32, Iss. 7, 2000-11 ,pp. : 2245-2247

Elsevier

Access to resources Recommend Favorite

Preemptive use of interferon or lamivudine for hepatitis B reactivation in patients with aggressive lymphoma receiving chemotherapy

By Leaw Shiang   Yen Chia   Huang Wen   Chen Tsai   Su Wu   Tsao Chao  

Annals of Hematology, Vol. 83, Iss. 5, 2004-05 ,pp. : 270-275

Springer Publishing Company

Access to resources Recommend Favorite

Reduced doses of hepatitis B immunoglobulin protect against hepatitis B virus infection recurrence after liver transplantation

By Cirera I.   Mas A.   Salmeron J.M.   Jimenez D.F.   Sanjose A.   Navasa M.   Rimola A.   Roca M.   Grande L.   Garcia-Valdecasas J.C.   Rodes J.  

Transplantation Proceedings, Vol. 33, Iss. 4, 2001-06 ,pp. : 2551-2553

Elsevier

Access to resources Recommend Favorite